Sponsorship

			PerkinElmer, a global leader in Health Sciences, provides instruments, reagents, software and services for drug discovery/development, genetic screening, environmental testing, quality assurance, and health sciences end markets. Our fully integrated solutions enhance productivity, optimize performance, accelerate time-to-market and ensure quality of results for pharmaceutical, biotech, academic research, clinical screening, environmental, and other high-growth markets.
			Roche Applied Science is a market-leading manufacturer and supplier of technologies for life science research, including biomolecular screening applications for drug discovery and development. Roche's enabling products and technologies include: o FuGENE® HD Transfection Reagent for enabling transfection, o LightCycler System for real-time PCR o 454 Sequencing o Nimblegen microarrays o xCELLigence System for real-time cellular analysis. Roche Applied Science products and technologies provide sensitive and specific results, simplify complex procedures, and increase productivity.
			Invitrogen Corporation develops technologies for life science research, drug development, and commercial bioproduction. We strive to accelerate biological understanding through technologies and services that include leading industry names such as GIBCO, Molecular Probes, Dynal, Quantum Dot, Zymed, and BioSource. Our product and service portfolio spans the breadth of drug discovery and development applications, as well as emerging areas such as diagnostics, nanotechnology, and regenerative medicine.
			MaxCyte specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of innovative therapeutic products. Drawing on its cell therapy expertise, MaxCyte has designed the MaxCyte STX Transfection System expressly for rapid, scalable, and reagent-free cell transfection for cell based assays, preclinical protein production, and other cell-based applications.
			Seahorse Bioscience's XF Extracellular Flux instruments create a transient microchamber within a cell culture plate that enables rapid and sensitive measurement of oxygen, protons and carbon dioxide. XF technology is impacting obesity, diabetes, and cancer drug discovery programs worldwide. To learn more about measuring metabolism in minutes visit www.seahorsebio.com
			Cisbio is an established provider of products and services for high-throughput drug discovery screening. We offer a comprehensive range of reagents to study targets related to oncology, inflammation, metabolic and cardiovascular disease, and central nervous system disorders. Cisbio products are used by pharmaceutical and biotechnology companies as well as CROs.